Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4151471000168110 | insulin glargine + lixisenatide (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4151481000168113 | insulin glargine + lixisenatide | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| insulin glargine + lixisenatide | Is a | lixisenatide | true | Inferred relationship | Some | ||
| insulin glargine + lixisenatide | Is a | insulin glargine | true | Inferred relationship | Some | ||
| insulin glargine + lixisenatide | has intended active ingredient | lixisenatide | true | Inferred relationship | Some | 1 | |
| insulin glargine + lixisenatide | has intended active ingredient | insulin glargine | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| insulin glargine 100 units/mL + lixisenatide 33 microgram/mL injection, pen device | Is a | True | insulin glargine + lixisenatide | Inferred relationship | Some | |
| insulin glargine 100 units/mL + lixisenatide 50 microgram/mL injection, pen device | Is a | True | insulin glargine + lixisenatide | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR